Golimumab: Difference between revisions
Content deleted Content added
No edit summary |
No edit summary |
||
| Line 25: | Line 25: | ||
| routes_of_administration = |
| routes_of_administration = |
||
}} |
}} |
||
'''Golimumab''' is a [[human]] [[monoclonal antibody]] which is used as an [[immunosuppressive drug]]. |
'''Golimumab''' is a [[human]] [[monoclonal antibody]] which is used as an [[immunosuppressive drug]]. Golimumab targets tumor necrosis factor alpha, a pro-inflammatory molecule. |
||
{{monoclonal-antibody-stub}} |
{{monoclonal-antibody-stub}} |
||
Revision as of 09:31, 28 June 2007
Template:Drugbox-mab Golimumab is a human monoclonal antibody which is used as an immunosuppressive drug. Golimumab targets tumor necrosis factor alpha, a pro-inflammatory molecule.
 | This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it. |